Metformin EP Impurity A

Electrochemical and Computational Insights on the Application of Expired Metformin Drug as a Novel Inhibitor for the Sweet Corrosion of C1018 Steel
Ikenna B. Onyeachu, Safwat Abdel-Azeim, Dheeraj Singh Chauhan, and Mumtaz A. Quraishi
ACS Omega 2021, 6, 1, 65–76
 
Development and validation of a hydrophilic interaction liquid chromatography method for the quantitation of impurities in fixed-dose combination tablets containing rosuvastatin and metformin
George Machairas, Irene Panderi, Ariadni Geballa- Koukoula, Stavroula Rozou, Nikolaos Antonopoulos, Christos Charitos, Ariadni Vonaparti
Talanta Volume 183, 1 June 2018, Pages 131-141
 
Determination of impurities in medical products containing metformin hydrochloride
gabriela k£aczkow* and eløbieta l. anuszewska
Acta Poloniae Pharmaceutica ñ Drug Research, Vol. 67 No. 6 pp. 593-598, 2010
 
Retention Behavior of Metformin and Related Impurities in Ion-Pairing Liquid Chromatography
Victor David and Andrei Medvedovici, Florin Albu
Journal of Liquid Chromatography & Related Technologiesw, 28: 81–95, 2005
 
Development of normal phase high-performance liquid chromatographic method for determination of metformin and its related impurities in bulk material
Imad Osman Abu Reid
The Pharma Innovation Journal 2017; 6(5): 157-160

Metformin EP Impurity A is chemically 1-Cyanoguanidine. It is also known as Metformin USP Related Compound A ; Dicyandiamide. Metformin EP Impurity A is supplied with detailed characterization data compliant with regulatory guideline. Metformin EP Impurity A can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Metformin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.